Danielle R Miller1,2, Mark W Logue1,3,4, Erika J Wolf1,2, Hannah Maniates1, Meghan E Robinson5,6,7, Jasmeet P Hayes1,2,5, Annjanette Stone8, Steven Schichman8, Regina E McGlinchey9,7,10, William P Milberg9,7,10, Mark W Miller1,2. 1. National Center for PTSD, VA Boston Healthcare System, Boston, MA, USA. 2. Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA. 3. Biomedical Genetics, Boston University School of Medicine, Boston, MA, USA. 4. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. 5. Neuroimaging Research for Veterans Center, VA Boston Healthcare System, Boston, MA, USA. 6. Department of Neurology, Boston University School of Medicine, Boston, MA, USA. 7. Translational Research Center for TBI and Stress Disorders, VA Boston Healthcare System, Boston, MA, USA, USA. 8. Pharmacogenomics Analysis Laboratory, Research Service, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA. 9. Geriatric Research, Educational, and Clinical Center, VA Boston Healthcare System, Boston, MA, USA, USA. 10. Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Accumulating evidence suggests that posttraumatic stress disorder (PTSD) is associated with disrupted default mode network (DMN) connectivity, but findings across studies have not been uniform. Individual differences in relevant genes may account for some of the reported variability in the relationship between DMN connectivity and PTSD. In this study, we investigated this possibility using genome-wide association study (GWAS) derived polygenic risk scores (PRSs) for relevant psychiatric traits. We hypothesized that the association between PTSD and DMN connectivity would be moderated by genetic risk for one or more psychiatric traits such that individuals with elevated polygenic risk for psychopathology and severe PTSD would exhibit disrupted DMN connectivity. METHODS: Participants were 156 white, non-Hispanic veterans of the wars in Iraq and Afghanistan who were genotyped and underwent resting state functional magnetic resonance imaging and clinical assessment. PRSs for neuroticism, anxiety, major depressive disorder, and cross-disorder risk (based on five psychiatric disorders) were calculated using summary statistics from published large-scale consortia-based GWASs. RESULTS: Cross-disorder polygenic risk influenced the relationship between DMN connectivity and PTSD symptom severity such that individuals at greater genetic risk showed a significant negative association between PTSD symptom severity and connectivity between the posterior cingulate cortex and right middle temporal gyrus. Polygenic risk for neuroticism, anxiety, and major depressive disorder did not influence DMN connectivity directly or through an interaction with PTSD. CONCLUSIONS: Findings illustrate the potential power of genome-wide PRSs to advance understanding of the relationship between PTSD and DMN connectivity, a putative neural endophenotype of the disorder.
BACKGROUND: Accumulating evidence suggests that posttraumatic stress disorder (PTSD) is associated with disrupted default mode network (DMN) connectivity, but findings across studies have not been uniform. Individual differences in relevant genes may account for some of the reported variability in the relationship between DMN connectivity and PTSD. In this study, we investigated this possibility using genome-wide association study (GWAS) derived polygenic risk scores (PRSs) for relevant psychiatric traits. We hypothesized that the association between PTSD and DMN connectivity would be moderated by genetic risk for one or more psychiatric traits such that individuals with elevated polygenic risk for psychopathology and severe PTSD would exhibit disrupted DMN connectivity. METHODS:Participants were 156 white, non-Hispanic veterans of the wars in Iraq and Afghanistan who were genotyped and underwent resting state functional magnetic resonance imaging and clinical assessment. PRSs for neuroticism, anxiety, major depressive disorder, and cross-disorder risk (based on five psychiatric disorders) were calculated using summary statistics from published large-scale consortia-based GWASs. RESULTS:Cross-disorder polygenic risk influenced the relationship between DMN connectivity and PTSD symptom severity such that individuals at greater genetic risk showed a significant negative association between PTSD symptom severity and connectivity between the posterior cingulate cortex and right middle temporal gyrus. Polygenic risk for neuroticism, anxiety, and major depressive disorder did not influence DMN connectivity directly or through an interaction with PTSD. CONCLUSIONS: Findings illustrate the potential power of genome-wide PRSs to advance understanding of the relationship between PTSD and DMN connectivity, a putative neural endophenotype of the disorder.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Jasmeet P Hayes; Mark W Logue; Naomi Sadeh; Jeffrey M Spielberg; Mieke Verfaellie; Scott M Hayes; Andrew Reagan; David H Salat; Erika J Wolf; Regina E McGlinchey; William P Milberg; Annjanette Stone; Steven A Schichman; Mark W Miller Journal: Brain Date: 2017-03-01 Impact factor: 13.501
Authors: Rebecca K Sripada; Anthony P King; Robert C Welsh; Sarah N Garfinkel; Xin Wang; Chandra S Sripada; Israel Liberzon Journal: Psychosom Med Date: 2012-10-31 Impact factor: 4.312
Authors: Mark W Miller; Erika J Wolf; Naomi Sadeh; Mark Logue; Jeffrey M Spielberg; Jasmeet P Hayes; Emily Sperbeck; Steven A Schichman; Angie Stone; Weleetka C Carter; Donald E Humphries; William Milberg; Regina McGlinchey Journal: Psychoneuroendocrinology Date: 2015-09-05 Impact factor: 4.905
Authors: Jennifer L Whitwell; Stephen D Weigand; Bradley F Boeve; Matthew L Senjem; Jeffrey L Gunter; Mariely DeJesus-Hernandez; Nicola J Rutherford; Matthew Baker; David S Knopman; Zbigniew K Wszolek; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Rosa Rademakers; Clifford R Jack; Keith A Josephs Journal: Brain Date: 2012-03 Impact factor: 13.501
Authors: Sergi G Costafreda; Peter McCann; Pascal Saker; James H Cole; Sarah Cohen-Woods; Anne E Farmer; Katherine J Aitchison; Peter McGuffin; Cynthia H Y Fu Journal: J Affect Disord Date: 2013-05-02 Impact factor: 4.839
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Teddy J Akiki; Christopher L Averill; Kristen M Wrocklage; J Cobb Scott; Lynnette A Averill; Brian Schweinsburg; Aaron Alexander-Bloch; Brenda Martini; Steven M Southwick; John H Krystal; Chadi G Abdallah Journal: Neuroimage Date: 2018-05-03 Impact factor: 6.556
Authors: Andrew A Nicholson; Daniela Rabellino; Maria Densmore; Paul A Frewen; Christian Paret; Rosemarie Kluetsch; Christian Schmahl; Jean Théberge; Tomas Ros; Richard W J Neufeld; Margaret C McKinnon; Jeffrey P Reiss; Rakesh Jetly; Ruth A Lanius Journal: Hum Brain Mapp Date: 2018-07-13 Impact factor: 5.038
Authors: Andrew A Nicholson; Sherain Harricharan; Maria Densmore; Richard W J Neufeld; Tomas Ros; Margaret C McKinnon; Paul A Frewen; Jean Théberge; Rakesh Jetly; David Pedlar; Ruth A Lanius Journal: Neuroimage Clin Date: 2020-04-22 Impact factor: 4.881
Authors: Andrew A Nicholson; Daniela Rabellino; Maria Densmore; Paul A Frewen; David Steryl; Frank Scharnowski; Jean Théberge; Richard W J Neufeld; Christian Schmahl; Rakesh Jetly; Ruth A Lanius Journal: Brain Behav Date: 2021-12-18 Impact factor: 2.708